Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome
- 6 October 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (14) , 1460-1471
- https://doi.org/10.1161/01.cir.98.14.1460
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.Journal of Clinical Investigation, 1995
- Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndromeHuman Molecular Genetics, 1993
- Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain geneJournal of the American College of Cardiology, 1993
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992
- Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1New England Journal of Medicine, 1989
- Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient PopulationNew England Journal of Medicine, 1989
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987
- Development and Progression of Left Ventricular Hypertrophy in Children with Hypertrophic CardiomyopathyNew England Journal of Medicine, 1986
- The Marfan Syndrome: Diagnosis and ManagementNew England Journal of Medicine, 1979